U.S. Software Stock News

BioCryst Pharmaceuticals (BCRX) has drawn investor attention recently as its share price shows mixed shorter term performance, with a small 1 day gain alongside negative moves over the past month and past 3 months. See our latest analysis for BioCryst Pharmaceuticals. At a share price of US$6.79, BioCryst’s recent 7 day share price return of 1.95% contrasts with a 30 day share price decline of 11.82%. Meanwhile, the 1 year total shareholder return of an 11.13% decline and the 3 year total...

In recent days, LendingClub drew attention after analysts at Citizens upgraded the company and JPMorgan reaffirmed it as a top pick, while the board approved a US$100,000,000 share repurchase program running through December 31, 2026. At the same time, LendingClub moved into the large home improvement financing market and deepened partnerships that extend its lending technology to smaller retailers nationwide. Next, we’ll examine how LendingClub’s new home improvement financing push could...

Rockwell Automation (ROK) is back in focus after expanding its collaboration with Lucid Group in Saudi Arabia, where its FactoryTalk MES software and training will support the Kingdom’s first vehicle manufacturing site. See our latest analysis for Rockwell Automation. The Lucid partnership and other recent customer wins arrive during a period of strong momentum, with a 30 day share price return of 4.93% and a 90 day share price return of 17.21%. The 1 year total shareholder return stands at...

Hormel Foods Corporation has appointed Domenic Borrelli as executive vice president of Retail, effective February 23, 2026, giving him oversight of its major branded consumer portfolio and key retail growth engine. Borrelli’s long track record leading multi-billion-dollar food and beverage businesses and complex transformations at Danone, Kraft, and Maple Leaf Foods signals a push to sharpen Hormel’s brand-building and retail execution at a pivotal time for its international and innovation...

Arm Holdings (NasdaqGS:ARM) has created a new Physical AI division focused on robotics and autonomous systems. The company is reorganizing its business lines to bring AI chip development and physical AI efforts under a clearer structure. The move reflects an effort to align Arm's architecture with growing demand for AI enabled robotics and autonomous vehicles. For you as an investor, this matters because Arm is known primarily for designing processor architectures used in smartphones, data...

Why analyst forecasts are drawing attention to NBT Bancorp (NBTB) Recent analyst forecasts for NBT Bancorp (NBTB) call for quarterly earnings per share of $0.99 and revenue of about $181.94 million, with expectations for higher net interest margin and stronger wealth management and insurance services income. See our latest analysis for NBT Bancorp. NBT Bancorp’s share price is at US$43.65, with a 90 day share price return of 6.67% and a 30 day return of 2.20%, while the 1 year total...

Nicolet Bankshares (NIC) is back in focus after reporting fourth quarter and full year 2025 results, with higher net income and earnings per share and revenue that topped forecasts, drawing fresh attention from investors. See our latest analysis for Nicolet Bankshares. The latest earnings release and dividend affirmation arrived after a strong run in the shares, with a 30 day share price return of 13.42% and year to date gain of 17.25%. The 1 year total shareholder return of 30.31% and 3 year...

Why Netflix (NFLX) is on investors’ radar right now Netflix (NFLX) shares have been under pressure recently, with the stock showing a negative move over the past month and past 3 months. This has prompted many investors to reassess what they are paying for its earnings power. See our latest analysis for Netflix. At a share price of $86.12, Netflix’s 30 day share price return of 8.03% and 90 day share price return of 21.33% contrast with a 3 year total shareholder return of 138.71% and 5 year...

DigitalOcean recently appointed Vinay Kumar as Chief Product and Technology Officer, tasking him with leading product strategy, cloud infrastructure, and security as the company scales its AI inference and core cloud offerings. The hire coincides with growing traction for DigitalOcean’s AI inference cloud, highlighted by its collaboration with Character.ai and AMD to boost large-scale production AI performance and efficiency. We’ll now examine how Vinay Kumar’s cloud platform experience and...

MillerKnoll (MLKN) recently drew fresh attention after being added to the Fortune World’s Most Admired Companies 2026 list, highlighting how the post merger furniture group is being viewed by global corporate peers. See our latest analysis for MillerKnoll. The recognition comes as MillerKnoll’s share price, last closing at US$19.59, shows a 30-day share price return of 8.23% and a 90-day share price return of 12.26%, even though the 1-year total shareholder return is a 9.33% decline. Recent...

If you are wondering whether Synaptics shares are offering fair value right now, it helps to look past the headlines and focus on what the numbers are actually saying. The stock last closed at US$85.60, with returns of 15.9% over 30 days and 13.0% year to date, although the 7 day return of a 6.0% decline and a 31.8% decline over three years show a mixed picture for longer term holders. Over the past year, Synaptics shares have returned 2.7%, while the 5 year return stands at a 13.7% decline...

Burke & Herbert Financial Services (BHRB) has capped FY 2025 with fourth quarter revenue of US$86.4 million and EPS of US$2.00, against a trailing twelve month tally of US$340.5 million in revenue and EPS of US$7.72. The company has seen revenue move from US$233.0 million and EPS of about US$2.83 on a trailing basis a year earlier to US$340.5 million and EPS of US$7.72, which helps explain why trailing net income is now US$116.4 million. With net margin reported at 34.2% for the latest twelve...

Madison Square Garden Entertainment Corp. has announced that international superstar Harry Styles will headline 30 consecutive shows at Madison Square Garden from August through October 2026, forming his only US dates that year and the largest single-venue stop on his Together, Together world tour. This residency, combined with MSGE’s record-breaking 2025 Christmas Spectacular attendance, advanced venue technology, and plans for new Sphere locations, highlights how the company is...

Recent commentary on Intellia Therapeutics (NTLA) is focused on safety concerns and regulatory pauses in its transthyretin amyloidosis program, as well as questions about commercial potential for its hereditary angioedema therapy. See our latest analysis for Intellia Therapeutics. Intellia's recent safety headlines come on top of sharp price swings. The company recorded a 1 day share price return of negative 7.99% following a 30 day share price return of 52.55%. Its 1 year total shareholder...

Earlier this week, Array Technologies was swept up in a broad market rally after the US President announced a framework for a future deal with Greenland that eased global trade tensions and lifted sentiment toward renewable energy and infrastructure names. The episode underlines how Array’s investment story can be heavily influenced by shifts in geopolitical risk and market appetite for renewables-linked assets rather than company-specific developments alone. Next, we’ll examine how this...

Medical Properties Trust (MPW) is back in focus as investors react to rising optimism around its upcoming earnings, with upward estimate revisions and heavy call option activity drawing fresh attention to the hospital focused REIT. See our latest analysis for Medical Properties Trust. At a share price of $5.11, Medical Properties Trust has seen mixed recent momentum, with a 1 year total shareholder return of 16.33% set against a 3 year total shareholder return decline of 48.25% and a 5 year...

Inspire Medical Systems recently appointed Matt Osberg as Executive Vice President and Chief Financial Officer, while also issuing updated revenue guidance for the fourth quarter of 2025, full-year 2025, and full-year 2026. These developments coincided with new uncertainty around Medicare reimbursement after two regional contractors removed a key billing code for the company’s hypoglossal nerve stimulation therapy, raising questions about how payment policies could interact with Inspire’s...

In recent days, Cheniere Energy has seen short interest fall markedly while multiple research firms have upgraded their views on the liquefied natural gas exporter, citing supportive demand and project progress. This combination of easing bearish positioning and more favorable analyst commentary signals a meaningful shift in how market participants assess the company’s risk-reward profile. Next, we’ll examine how the sharp reduction in short interest influences Cheniere Energy’s investment...

Earlier this week, Guardant Health received FDA approval for its Guardant360 CDx liquid biopsy as a companion diagnostic to identify BRAF V600E-mutant metastatic colorectal cancer patients eligible for treatment with BRAFTOVI (encorafenib) plus cetuximab and chemotherapy. This marks the test’s first approval in colorectal cancer and its 25th companion diagnostic indication overall, underscoring the expanding role of non-invasive genomic profiling in tailoring treatment when tissue samples...

What Novo Nordisk’s recent performance data tells you Novo Nordisk (NYSE:NVO) has posted mixed return figures, with the share price roughly flat over the past week and slightly higher over the past day, while showing stronger gains over the past month and past 3 months. At the same time, longer term data is uneven, with a negative 1 year total return and a modest negative 3 year total return, set against a very large 5 year total return that points to a materially different outcome for...

United Bancshares (UBOH) has rounded out FY 2025 with fourth quarter total revenue of US$12.6 million and basic EPS of US$1.04, alongside trailing twelve month revenue of US$47.0 million and EPS of US$4.04 that cap a year of stronger profitability. The company has seen total revenue move from US$41.8 million and EPS of US$3.06 on a trailing basis at the end of 2024 to US$47.0 million and US$4.04 respectively, setting up this latest report as a key reference point for how investors judge the...

SLM (SLM) closed out FY 2025 with Q4 revenue of US$472.9 million and basic EPS of US$1.14, while trailing 12 month EPS sat at US$3.52 on revenue of about US$1.7 billion. The company has seen quarterly revenue move from US$281.8 million and EPS of US$0.51 in Q4 FY 2024 to US$472.9 million and EPS of US$1.14 in Q4 FY 2025, alongside trailing 12 month EPS shifting between US$2.73 and US$3.52 over the same window. For investors, the combination of higher trailing margins and these headline...

nLIGHT (NasdaqGS:LASR) has appointed a defense technology veteran to its board of directors. The move is intended to deepen the company’s engagement with aerospace and defense customers. This development is separate from earnings guidance, analyst calls, or broader market moves. For investors watching nLIGHT at a share price of $43.93, the new board member arrives as the company is coming off a period of strong stock performance, including a 270.7% return over the past year and 258.3% over...

Neurocrine Biosciences (NBIX) shares are in focus after new clinical data showed its VMAT2 inhibitor INGREZZA achieved higher target occupancy and greater potency than AUSTEDO XR at therapeutic doses in hyperkinetic movement disorders. See our latest analysis for Neurocrine Biosciences. At a share price of US$136.18, Neurocrine Biosciences has seen a 7.32% 30 day share price decline and a 3.14% year to date share price pullback. Its 3 year total shareholder return of 25.80% contrasts with a 1...